Nova Mentis Life Science Corp (NOVA.CX)
0.015
0.00 (0.00%)
CAD |
CNSX |
May 03, 12:26
Nova Mentis Life Science Cash from Financing (TTM)
Cash from Financing (TTM) Chart
Historical Cash from Financing (TTM) Data
| Date | Value |
|---|---|
| March 31, 2023 | 0.0275M |
| December 31, 2022 | 1.491M |
| September 30, 2022 | 1.483M |
| June 30, 2022 | 1.483M |
| March 31, 2022 | 1.483M |
| December 31, 2021 | 0.00 |
| September 30, 2021 | |
| June 30, 2021 | |
| March 31, 2021 | |
| December 31, 2020 | |
| September 30, 2020 | |
| June 30, 2020 | |
| March 31, 2020 | 0.15M |
| December 31, 2019 | 0.15M |
| September 30, 2019 | 0.5531M |
| June 30, 2019 | 0.7904M |
| March 31, 2019 | 0.7122M |
| December 31, 2018 | 3.054M |
| September 30, 2018 | 3.950M |
| June 30, 2018 | 3.811M |
| March 31, 2018 | 4.105M |
| December 31, 2017 | 2.220M |
| September 30, 2017 | 1.958M |
| June 30, 2017 | 1.988M |
| March 31, 2017 | 1.681M |
| Date | Value |
|---|---|
| December 31, 2016 | 1.226M |
| September 30, 2016 | 0.6429M |
| June 30, 2016 | 0.6938M |
| March 31, 2016 | 0.6938M |
| December 31, 2015 | 0.8443M |
| September 30, 2015 | 0.47M |
| June 30, 2015 | 0.6207M |
| March 31, 2015 | 0.722M |
| December 31, 2014 | 0.5715M |
| September 30, 2014 | 0.4914M |
| June 30, 2014 | 0.1013M |
| March 31, 2014 | 0.00 |
| December 31, 2013 | 0.129M |
| September 30, 2013 | 0.129M |
| June 30, 2013 | 0.129M |
| March 31, 2013 | 0.129M |
| December 31, 2012 | 0.00 |
| September 30, 2012 | 0.00 |
| June 30, 2012 | 1.946M |
| March 31, 2012 | 2.246M |
| December 31, 2011 | 2.494M |
| September 30, 2011 | 3.066M |
| June 30, 2011 | 1.101M |
| March 31, 2011 | 0.8002M |
| December 31, 2010 | 0.895M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (TTM) Range, Past 5 Years
--
Minimum
Dec 2021
1.491M
Maximum
Dec 2022
0.7611M
Average
0.6718M
Median
Cash from Financing (TTM) Benchmarks
| Biocure Technology Inc | 0.3224M |
| Core One Labs Inc | -- |
| Nanosphere Health Sciences Inc | -- |
| Lobe Sciences Ltd | 1.527M |
| Algernon Pharmaceuticals Inc | 2.158M |